The primary goal of this intervention is to determine the efficacy of acute mitochondrial-specific antioxidants to improve vascular endothelial function in middle-aged and older (≥45 y) adults who do no perform regular aerobic exercise. In a double-blind, randomized, placebo-controlled crossover design participants with receive both MitoQ and placebo arm of the study. Primary endpoints will include vascular endothelial function assessed by brachial artery flow-mediated dilation and cardiac function assessed via pulse wave analysis. Secondary endpoints will include measures of aortic stiffness assessed by carotid-femoral pulse wave velocity and carotid artery stiffness (e.g. β-stiffness) and elasticity (carotid compliance, distensibility, and Youngs elastic modulus) from ultrasonography.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Enrollment
23
Gelatin capsules
MitoQ was given once (single dose, 80 mg)
Ball State University
Muncie, Indiana, United States
Change in vascular endothelial function
Brachial artery flow-mediated dilation (% \[relative\] and mm \[absolute\])
Time frame: Baseline and Post 1 hour
Change in cardiovascular function
Subendocardial viability ratio (%)
Time frame: Baseline and Post 1 hour
Change in Aortic Stiffness
Carotid-femoral pulse wave velocity (meters/second)
Time frame: Baseline and Post 1 hour
Change in carotid artery stiffness - beta-stiffness index
Carotid artery Beta stiffness index (AU)
Time frame: Baseline and Post 1 hour
Change in carotid artery compliance
Carotid artery compliance (mmHg/mm\^2)
Time frame: Baseline and Post 1 hour
Change in carotid artery distensibility
Carotid artery distensibility (10\^-3/kilopascals)
Time frame: Baseline and Post 1 hour
Change in carotid artery Young's elastic modulus
Carotid artery Young's elastic modulus (kilopascals, kPa)
Time frame: Baseline and Post 1 hour
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.